Stoneridge Investment Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,565
Closed -$1.71M 145
2025
Q3
$1.71M Buy
6,565
+2,423
+58% +$637K 1.17% 30
2025
Q2
$1.01M Sell
4,142
-5,871
-59% -$1.46M 0.76% 41
2025
Q1
$2.65M Buy
+10,013
New +$2.71M 2.24% 12
2024
Q4
Sell
-4,065
Closed -$1.29M 154
2024
Q3
$1.29M Buy
+4,065
New +$1.45M 0.48% 57
2024
Q2
Sell
-13,940
Closed -$4.83M 139
2024
Q1
$4.83M Buy
13,940
+10,287
+282% +$3.9M 1.84% 13
2023
Q4
$1.67M Buy
+3,653
New +$1.8M 0.7% 48
2021
Q2
Sell
-2,248
Closed -$942K 114
2021
Q1
$942K Buy
+2,248
New +$897K 0.49% 63
2019
Q2
Sell
-3,826
Closed -$1.02M 131
2019
Q1
$1.02M Buy
3,826
+632
+20% +$182K 0.3% 87
2018
Q4
$915K Buy
+3,194
New +$1.01M 0.29% 93
2018
Q1
Sell
-36,335
Closed -$9.01M 225
2017
Q4
$9.01M Buy
+36,335
New +$8.97M 1.44% 14
2013
Q4
Sell
-14,226
Closed -$1.33M 217
2013
Q3
$1.33M Sell
14,226
-600
-4% -$55K 0.29% 85
2013
Q2
$1.25M Buy
+14,826
New +$1.17M 0.29% 86

Other funds holding HUM

Stoneridge Investment Partners's HUM Position: Q4 2025 in Review

Stoneridge Investment Partners sold out of Humana (HUM) in Q4 2025, closing a stake of 6,565 shares — an estimated $1.71M sold.

Stoneridge Investment Partners first reported a position in HUM in Q2 2013 and held it in 12 quarters. The position peaked at $9.01M in Q4 2017. 862 funds tracked by Wall St. Rank hold HUM as of Q4 2025.

  • Stoneridge Investment Partners reported no remaining Humana position as of Q4 2025 after selling out during the quarter.
  • Stoneridge Investment Partners sold 6,565 Humana shares in Q4 2025, an estimated $1.71M.
  • Stoneridge Investment Partners first reported a position in Humana in Q2 2013 and held it in 12 quarters.
  • Stoneridge Investment Partners's Humana position peaked at $9.01M in Q4 2017.
  • 862 funds tracked by Wall St. Rank held Humana as of Q4 2025.

Based on Stoneridge Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.